Klee Justin B.
Insider CIK 1898314 · AMLX Co-Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 29,025 | $32.13 | $932.6K | 3,614,495 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 1,439 | $33.16 | $47.7K | 3,613,056 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 1,439 | $33.16 | $47.7K | 3,613,056 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 29,025 | $32.13 | $932.6K | 3,614,495 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,520 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 60,039 | — | $0 | 3,643,520 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 373,295 | — | $0 | 373,295 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-03-05 | 2026-03-09 | 248,865 | — | $0 | 3,583,481 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-03-02 | 2026-03-04 | 29,282 | $14.47 | $423.7K | 3,334,616 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-02-02 | 2026-02-04 | 15,500 | $14.69 | $227.7K | 3,363,898 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2026-01-16 | 2026-01-20 | 2,847 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-16 | 2026-01-20 | 1,995 | $13.89 | $27.7K | 3,379,398 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2026-01-16 | 2026-01-20 | 2,847 | $7.57 | $21.6K | 3,381,393 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2026-01-15 | 2026-01-20 | 197,153 | — | $0 | 2,847 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-15 | 2026-01-20 | 136,193 | $13.58 | $1.85M | 3,378,546 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2026-01-15 | 2026-01-20 | 197,153 | $7.57 | $1.49M | 3,514,739 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-08 | 7,715 | $11.09 | $85.6K | 3,317,586 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 200 | $15.01 | $3.0K | 3,325,301 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 29,775 | $14.37 | $427.9K | 3,325,501 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-31 | 2025-04-02 | 21,490 | $3.46 | $74.4K | 3,355,276 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2025-03-06 | 2025-03-10 | 270,177 | — | $0 | 270,177 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2025-03-06 | 2025-03-10 | 180,118 | — | $0 | 3,376,766 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-03 | 2025-03-05 | 4,595 | $3.15 | $14.5K | 3,196,648 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2025-02-05 | 2025-02-06 | 36,310 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2025-02-05 | 2025-02-06 | 36,310 | $1.57 | $57.0K | 3,201,243 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-02-03 | 2025-02-05 | 11,855 | $3.47 | $41.1K | 3,164,933 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-01-06 | 2025-01-08 | 7,471 | $4.04 | $30.2K | 3,176,788 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2024-11-04 | 2024-11-06 | 63,690 | — | $0 | 36,310 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2024-11-04 | 2024-11-06 | 63,690 | $1.57 | $100.0K | 3,184,259 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-09-30 | 2024-10-02 | 18,589 | $3.20 | $59.5K | 3,120,569 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-04-16 | 2024-04-18 | 380,000 | — | $0 | 380,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-04-16 | 2024-04-18 | 179,850 | — | $0 | 3,139,158 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-03-05 | 2024-03-07 | 4,135 | $18.73 | $77.4K | 2,959,308 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-02-26 | 2024-02-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-02-26 | 2024-02-28 | 126,667 | — | $0 | 2,963,443 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-01-09 | 2024-01-11 | 5,841 | $16.33 | $95.4K | 2,836,776 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-03-16 | 2023-03-20 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 3,445 | $32.48 | $111.9K | 2,792,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-03-16 | 2023-03-20 | 50,000 | — | $0 | 2,842,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-20 | 96,555 | $31.84 | $3.07M | 2,796,062 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 4,122 | $36.08 | $148.7K | 2,894,463 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-01-06 | 2023-01-10 | 1,846 | $36.79 | $67.9K | 2,892,617 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise deriv | 2022-05-05 | 2022-05-06 | 334,520 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | M Exercise | 2022-05-05 | 2022-05-06 | 334,520 | $0.37 | $123.8K | 2,898,585 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-06 | 2022-01-10 | 4,870 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2022-01-06 | 2022-01-10 | 337,500 | — | $0 | 337,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2022-01-06 | 2022-01-10 | 75,000 | — | $0 | 2,564,065 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-06 | 2022-01-10 | 4,870 | — | $0 | 2,489,065 | SEC↗ |